Related references
Note: Only part of the references are listed.Nrf2-ME-1 axis is associated with 5-FU resistance in gastric cancer cell line
Farhad Pouremamali et al.
PROCESS BIOCHEMISTRY (2022)
The role of SOX family transcription factors in gastric cancer
Asal Jalal Abadi et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)
Nrf2 Signaling Pathway in Chemoprotection and Doxorubicin Resistance: Potential Application in Drug Discovery
Sepideh Mirzaei et al.
ANTIOXIDANTS (2021)
Nrf2 signaling pathway in cisplatin chemotherapy: Potential involvement in organ protection and chemoresistance
Sepideh Mirzaei et al.
PHARMACOLOGICAL RESEARCH (2021)
Back to Nucleus: Combating with Cadmium Toxicity Using Nrf2 Signaling Pathway as a Promising Therapeutic Target
Milad Ashrafizadeh et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2020)
Curcumin Activates the Nrf2 Pathway and Induces Cellular Protection Against Oxidative Injury
Milad Ashrafizadeh et al.
CURRENT MOLECULAR MEDICINE (2020)
Therapeutic and biological activities of berberine: The involvement of Nrf2 signaling pathway
Milad Ashrafizadeh et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2020)
MicroRNA-mediated regulation of Nrf2 signaling pathway: Implications in disease therapy and protection against oxidative stress
Milad Ashrafizadeh et al.
LIFE SCIENCES (2020)
Perplexing Role of P-Glycoprotein in Tumor Microenvironment
Kianna Robinson et al.
FRONTIERS IN ONCOLOGY (2020)
Baicalein enhanced cisplatin sensitivity of gastric cancer cells by inducing cell apoptosis and autophagy via Akt/mTOR and Nrf2/Keap 1 pathway
Ping Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
PTEN, a Barrier for Proliferation and Metastasis of Gastric Cancer Cells: From Molecular Pathways to Targeting and Regulation
Milad Ashrafizadeh et al.
BIOMEDICINES (2020)
STAT3 Pathway in Gastric Cancer: Signaling, Therapeutic Targeting and Future Prospects
Milad Ashrafizadeh et al.
BIOLOGY-BASEL (2020)
DJ-1 is involved in the multidrug resistance of SGC7901 gastric cancer cells through PTEN/PI3K/Akt/Nrf2 pathway
Lejia Qiu et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2020)
Wnt-regulating microRNAs role in gastric cancer malignancy
Milad Ashrafizadeh et al.
LIFE SCIENCES (2020)
Nrf2 Inhibitor, Brusatol in Combination with Trastuzumab Exerts Synergistic Antitumor Activity in HER2-Positive Cancers by Inhibiting Nrf2/HO-1 and HER2-AKT/ERK1/2 Pathways
Yun Yang et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Sensing the scent of death: Modulation of microRNAs by Curcumin in gastrointestinal cancers
Milad Ashrafizadeh et al.
PHARMACOLOGICAL RESEARCH (2020)
Updates on Management of Gastric Cancer
Fabian M. Johnston et al.
CURRENT ONCOLOGY REPORTS (2019)
DJ-1 overexpression confers the multidrug resistance phenotype to SGC7901 cells by upregulating P-gp and Bcl-2
Hao-Yue Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
The Role of Nrf2 Activity in Cancer Development and Progression
Alina-Andreea Zimta et al.
CANCERS (2019)
NRF2 through RPS6 Activation Is Related to Anti-HER2 Drug Resistance in HER2-Amplified Gastric Cancer
Valentina Gambardella et al.
CLINICAL CANCER RESEARCH (2019)
TCF7L1 indicates prognosis and promotes proliferation through activation of Keap1/NRF2 in gastric cancer
Beili Zhang et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2019)
The effects of NRF2 modulation on the initiation and progression of chemically and genetically induced lung cancer
Shasha Tao et al.
MOLECULAR CARCINOGENESIS (2018)
Nrf2 overexpression is associated with P-glycoprotein upregulation in gastric cancer
Farhad Jeddi et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised, placebo-controlled phase 3 study
Josep Tabernero et al.
LANCET ONCOLOGY (2018)
Adjuvant chemoradiation for gastric carcinoma: State of the art and perspectives
A. Schernberg et al.
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2018)
Targeting Signalling Pathways in Hepatocellular Carcinoma
Kaja Blagotinsek et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study
Peter C. Thuss-Patience et al.
LANCET ONCOLOGY (2017)
Expression of the NRF2 Target Gene NQO1 Is Enhanced in Mononuclear Cells in Human Chronic Kidney Disease
Jianlin Shen et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature
Yu-ying Lei et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2017)
Baicalein: A review of its anti-cancer effects and mechanisms in Hepatocellular Carcinoma
Beibei Bie et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Diallyl trisulfide suppresses tumor growth through the attenuation of Nrf2/Akt and activation of p38/JNK and potentiates cisplatin efficacy in gastric cancer treatment
Xiao-yan Jiang et al.
ACTA PHARMACOLOGICA SINICA (2017)
Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors
Anju Singh et al.
ACS CHEMICAL BIOLOGY (2016)
Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism
Agnieszka Loboda et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Nrf2 protects mitochondrial decay by oxidative stress
Joshua Strom et al.
FASEB JOURNAL (2016)
Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC-A Randomized Phase III Trial
J. Randolph Hecht et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Anticancer properties of baicalein: a review
Ying Gao et al.
MEDICINAL CHEMISTRY RESEARCH (2016)
NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis
Hui Wang et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Knockdown of long non-coding RNA TP73-AS1 inhibits cell proliferation and induces apoptosis in esophageal squamous cell carcinoma
Wenqiao Zang et al.
ONCOTARGET (2016)
TCF7L1 Modulates Colorectal Cancer Growth by Inhibiting Expression of the Tumor-Suppressor Gene EPHB3
Matthew Murphy et al.
SCIENTIFIC REPORTS (2016)
p62 links autophagy and Nrf2 signaling
Tao Jiang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Dual roles of NRF2 in tumor prevention and progression: Possible implications in cancer treatment
Eui Jung Moon et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
T Lymphocyte-Specific Activation of Nrf2 Protects from AKI
Sanjeev Noel et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Oxidative stress inhibits distant metastasis by human melanoma cells
Elena Piskounova et al.
NATURE (2015)
Malic enzyme 1 induces epithelial-mesenchymal transition and indicates poor prognosis in hepatocellular carcinoma
Duo Wen et al.
TUMOR BIOLOGY (2015)
Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer
Taroh Satoh et al.
GASTRIC CANCER (2015)
Diallyl trisulfide inhibits migration, invasion and angiogenesis of human colon cancer HT-29 cells and umbilical vein endothelial cells, and suppresses murine xenograft tumour growth
Kuang-Chi Lai et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics
Carlos L. Arteaga et al.
CANCER CELL (2014)
Nrf2 Protects Pancreatic β-Cells From Oxidative and Nitrosative Stress in Diabetic Model Mice
Yoko Yagishita et al.
DIABETES (2014)
Oncogenic potential of Nrf2 and its principal target protein heme oxygenase-1
Hye-Kyung Na et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Lapatinib Plus Paclitaxel Versus Paclitaxel Alone in the Second-Line Treatment of HER2-Amplified Advanced Gastric Cancer in Asian Populations: TyTANA- A Randomized, Phase III Study
Taroh Satoh et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
Hansjochen Wilke et al.
LANCET ONCOLOGY (2014)
DJ-1 is involved in the peritoneal metastasis of gastric cancer through activation of the Akt signaling pathway
Zheng-Ming Zhu et al.
ONCOLOGY REPORTS (2014)
Treatment of gastric cancer
Michele Orditura et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Role of Nrf2 in Oxidative Stress and Toxicity
Qiang Ma
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 53, 2013 (2013)
Nrf2 Overexpression Predicts Prognosis and 5-FU Resistance in Gastric Cancer
Xiu-Feng Hu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation
Holly K. Bryan et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Critical role for reactive oxygen species in apoptosis induction and cell migration inhibition by diallyl trisulfide, a cancer chemopreventive component of garlic
Kumar Chandra-Kuntal et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Nrf2 Prevents Initiation but Accelerates Progression through the Kras Signaling Pathway during Lung Carcinogenesis
Hironori Satoh et al.
CANCER RESEARCH (2013)
The emerging role of the Nrf2-Keap1 signaling pathway in cancer
Melba C. Jaramillo et al.
GENES & DEVELOPMENT (2013)
The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer
Emilia Kansanen et al.
REDOX BIOLOGY (2013)
Human BDH2, an anti-apoptosis factor, is a novel poor prognostic factor for de novo cytogenetically normal acute myeloid leukemia
Wen-Chi Yang et al.
JOURNAL OF BIOMEDICAL SCIENCE (2013)
Control of Breast Cancer Growth and Initiation by the Stem Cell-Associated Transcription Factor TCF3
Michal Slyper et al.
CANCER RESEARCH (2012)
Updated Analysis of SWOG-Directed Intergroup Study 0116: A Phase III Trial of Adjuvant Radiochemotherapy Versus Observation After Curative Gastric Cancer Resection
Stephen R. Smalley et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Phase 2 Trial of Bevacizumab, Capecitabine, and Oxaliplatin in Treatment of Advanced Hepatocellular Carcinoma
Weijing Sun et al.
CANCER (2011)
Autophagy Activation in Hepatocellular Carcinoma Contributes to the Tolerance of Oxaliplatin via Reactive Oxygen Species Modulation
Zhen-Bin Ding et al.
CLINICAL CANCER RESEARCH (2011)
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
Gina M. De Nicola et al.
NATURE (2011)
Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer A Meta-analysis
Xavier Paoletti et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study
Birgit Gruenberger et al.
LANCET ONCOLOGY (2010)
Direct Interaction between Nrf2 and p21Cip1/WAF1 Upregulates the Nrf2-Mediated Antioxidant Response
Weimin Chen et al.
MOLECULAR CELL (2009)
NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer
John D. Hayes et al.
TRENDS IN BIOCHEMICAL SCIENCES (2009)
被撤回的出版物: Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1 (Retracted article. See vol. 193, pg. 344, 2016)
Deepti Malhotra et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Smoking and gastric cancer: systematic review and meta-analysis of cohort studies
Ricardo Ladeiras-Lopes et al.
CANCER CAUSES & CONTROL (2008)
The role of postoperative adjuvant chemotherapy following curative resection for gastric cancer: A meta-analysis
Shu-Liang Zhao et al.
CANCER INVESTIGATION (2008)
Multitargeted prevention and therapy of cancer by diallyl trisulfide and related Allium vegetable-derived organosulfur compounds
Anna A. Powolny et al.
CANCER LETTERS (2008)
An updated meta-analysis of adjuvant chemotherapy after curative resection for gastric cancer
T. S. Liu et al.
EJSO (2008)
Dual roles of Nrf2 in cancer
Alexandria Lau et al.
PHARMACOLOGICAL RESEARCH (2008)
The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis
M. M. Moasser
ONCOGENE (2007)
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
James A. McCubrey et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Combined modalities of resistance in an oxaliplatin-resistant human gastric cancer cell line with enhanced sensitivity to 5-fluorouracil
C-C Chen et al.
BRITISH JOURNAL OF CANCER (2007)
Tobacco smoking and gastric cancer risk: An evaluation based on a systematic review of epidemiologic evidence among the Japanese population
Yoshikazu Nishino et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2006)
DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2
Casey M. Clements et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Characterization of human DHRS6, an orphan short chain dehydrogenase/reductase enzyme -: A novel, cytosolic type 2 R-β-hydroxybutyrate dehydrogenase
K Guo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Mechanisms of disease: PI3K/AKT signaling in gastrointestinal cancers
P Michl et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2005)
Nrf2 as a novel molecular target for chemoprevention
JS Lee et al.
CANCER LETTERS (2005)
DJ-1, a novel regulator of the tumor suppressor PTEN
RH Kim et al.
CANCER CELL (2005)
Laparoscopic versus open subtotal gastrectomy for distal gastric cancer - Five-year results of a randomized prospective trial
CGS Huscher et al.
ANNALS OF SURGERY (2005)
Lymphoid enhancer factor/T cell factor expression in colorectal cancer
ML Waterman
CANCER AND METASTASIS REVIEWS (2004)
Drug specific resistance to oxaliplatin is associated with apoptosis defect in a cellular model of colon carcinoma
I Gourdier et al.
FEBS LETTERS (2002)
The cellular pharmacology of oxaliplatin resistance
M Mishima et al.
EUROPEAN JOURNAL OF CANCER (2002)
Chemotherapy in gastric cancer: a review and updated meta-analysis
KG Janunger et al.
EUROPEAN JOURNAL OF SURGERY (2002)
Baicalein attenuates oxidant stress in cardiomyocytes
ZH Shao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)
Oxaliplatin:: available data in non-colorectal gastrointestinal malignancies
Y Bécouarn et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2001)
Share Paper
